Trinity Biotech Plc (TRIB)
0.7336
-0.01
(-1.16%)
USD |
NASDAQ |
Jan 09, 16:00
0.7336
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Research and Development Expense (Annual): 4.535M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amarin Corp. Plc | 17.86M |
| DBV Technologies SA | 89.90M |
| Ascendis Pharma A/S | 324.02M |
| Cellectis SA | 72.02M |
| Akari Therapeutics Plc | 6.986M |